Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1970 2
1971 2
1972 1
1974 1
1977 2
1979 1
1980 2
1982 1
1983 1
1986 1
1987 2
1989 1
1990 3
1992 3
1993 2
1994 1
1995 1
1996 2
1999 4
2000 2
2001 3
2002 2
2003 2
2004 2
2005 1
2006 1
2008 2
2009 5
2010 4
2011 1
2012 1
2013 3
2014 2
2016 1
2019 1
2020 2
2021 3
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
Maternal phenylketonuria.
Paprocka J, Jamroz E, Wiktor M, Marszał E. Paprocka J, et al. Wiad Lek. 2009;62(1):11-7. Wiad Lek. 2009. PMID: 19817251
The maternal phenylketonuria (MPKU) syndrome is an example of biochemical teratogenesis caused by high phenylalanine concentrations in serum of a pregnant woman (over 360 micromol/L). ...Increased phenylalanine concentrations may lead to disorders in proliferation o …
The maternal phenylketonuria (MPKU) syndrome is an example of biochemical teratogenesis caused by high phenylalanine concentra …
Maternal phenylketonuria.
Arthur LJ. Arthur LJ. Br Med J. 1970 Nov 14;4(5732):431. doi: 10.1136/bmj.4.5732.431. Br Med J. 1970. PMID: 5481526 Free PMC article. No abstract available.
Maternal phenylketonuria.
[No authors listed] [No authors listed] Br Med J. 1970 Oct 24;4(5729):192. Br Med J. 1970. PMID: 5472778 Free PMC article. No abstract available.
Tyrosine supplementation for phenylketonuria.
Remmington T, Smith S. Remmington T, et al. Cochrane Database Syst Rev. 2021 Jan 4;1(1):CD001507. doi: 10.1002/14651858.CD001507.pub4. Cochrane Database Syst Rev. 2021. PMID: 33427303 Free PMC article.
SELECTION CRITERIA: All randomised or quasi-randomised trials investigating the use of tyrosine supplementation versus placebo in people with phenylketonuria in addition to, or instead of, a phenylalanine-restricted diet. People treated for maternal phenylketonuria
SELECTION CRITERIA: All randomised or quasi-randomised trials investigating the use of tyrosine supplementation versus placebo in people wit …
Guide for diagnosis and treatment of hyperphenylalaninemia.
Shintaku H, Ohura T, Takayanagi M, Kure S, Owada M, Matsubara Y, Yoshino M, Okano Y, Ito T, Okuyama T, Nakamura K, Matuo M, Endo F, Ida H. Shintaku H, et al. Pediatr Int. 2021 Jan;63(1):8-12. doi: 10.1111/ped.14399. Epub 2021 Jan 10. Pediatr Int. 2021. PMID: 33423362
Although there are reports that sapropterin hydrochloride is effective and safe for the prevention of maternal phenylketonuria, further investigation is required....
Although there are reports that sapropterin hydrochloride is effective and safe for the prevention of maternal phenylketonuria
Tyrosine supplementation for phenylketonuria.
Webster D, Wildgoose J. Webster D, et al. Cochrane Database Syst Rev. 2013 Jun 5;2013(6):CD001507. doi: 10.1002/14651858.CD001507.pub3. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2021 Jan 4;1:CD001507. doi: 10.1002/14651858.CD001507.pub4. PMID: 23737086 Free PMC article. Updated. Review.
SELECTION CRITERIA: All randomised or quasi-randomised trials investigating the use of tyrosine supplementation versus placebo in people with phenylketonuria in addition to, or instead of, a phenylalanine-restricted diet. People treated for maternal phenylketonuria
SELECTION CRITERIA: All randomised or quasi-randomised trials investigating the use of tyrosine supplementation versus placebo in people wit …
Adult phenylketonuria.
Hanley WB. Hanley WB. Am J Med. 2004 Oct 15;117(8):590-5. doi: 10.1016/j.amjmed.2004.03.042. Am J Med. 2004. PMID: 15465508 Review.
However, there are few adult physicians dedicated to continuing care of this group, with the possible exception of maternal phenylketonuria. Up to 10% of adults with classic phenylketonuria, and possibly 50% of those with milder variants, may not need treatment; aft …
However, there are few adult physicians dedicated to continuing care of this group, with the possible exception of maternal phenyl
Tyrosine supplementation for phenylketonuria.
Webster D, Wildgoose J. Webster D, et al. Cochrane Database Syst Rev. 2010 Aug 4;(8):CD001507. doi: 10.1002/14651858.CD001507.pub2. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2013 Jun 05;(6):CD001507. doi: 10.1002/14651858.CD001507.pub3. PMID: 20687067 Updated. Review.
SELECTION CRITERIA: All randomised or quasi-randomised trials investigating the use of tyrosine supplementation versus placebo in people with phenylketonuria in addition to, or instead of, a phenylalanine-restricted diet. People treated for maternal phenylketonuria
SELECTION CRITERIA: All randomised or quasi-randomised trials investigating the use of tyrosine supplementation versus placebo in people wit …
Maternal phenylketonuria: a metabolic teratogen.
Levy HL, Ghavami M. Levy HL, et al. Teratology. 1996 Mar;53(3):176-84. doi: 10.1002/(SICI)1096-9926(199603)53:3<176::AID-TERA5>3.0.CO;2-2. Teratology. 1996. PMID: 8761885 Review.
The maternal phenylketonuria (PKU) syndrome refers to the teratogenic effects of PKU during pregnancy. ...
The maternal phenylketonuria (PKU) syndrome refers to the teratogenic effects of PKU during pregnancy. ...
72 results